Lin Luo

Title: Lin Luo: Innovator in Antibody Quantitation

Introduction

Lin Luo is a prominent inventor based in Paramus, NJ (US), known for his significant contributions to the field of antibody quantitation. With a total of 4 patents to his name, he has made strides in developing methods that enhance the accuracy and efficiency of measuring individual antibodies from complex mixtures.

Latest Patents

Among his latest patents, Lin has developed innovative methods for quantitating individual antibodies from a mixture. This method involves separating antibody molecules using hydrophobic interaction chromatography high performance liquid chromatography (HIC-HPLC). The process allows for the quantitation of each antibody molecule, ensuring that the molecular weight of each is within 15 kDa of others in the mixture. Furthermore, it distinguishes between antibody molecules based on their hydropathy scale or distinct elution times, minimizing overlap during analysis.

Career Highlights

Lin Luo is currently employed at Regeneron Pharmaceuticals, Inc., where he applies his expertise in antibody research. His work has been instrumental in advancing the methodologies used in the biopharmaceutical industry, particularly in the development of therapeutic antibodies.

Collaborations

Lin collaborates with notable colleagues, including Dingjiang Liu and Long Xu, who contribute to his research endeavors and innovations in the field.

Conclusion

Lin Luo's work in antibody quantitation exemplifies the impact of innovative research in biotechnology. His patents and contributions continue to shape the future of antibody analysis and therapeutic development.